Biotech Investors Fortify Jefferies Arbitration Battle
By Cara Mannion ( April 17, 2017, 1:58 PM EDT) -- Shareholders who bought stock in a since-failed biotech company are bringing counterclaims against Jefferies LLC if they cannot arbitrate their dispute before the Financial Industry Regulatory Authority, telling a Texas federal court Friday that the investment banking firm failed to properly investigate the biotech securities before recommending them....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.